# FDA Inspection 645399 - Nassau Health Care Corporation d/b/a/ NuHealth - February 16, 2010

Source: https://www.keypedia.com/records/fda_inspections/nassau-health-care-corporation-dba-nuhealth/c1e93d41-e66a-48ad-a9ad-c8805f4464df
Source feed: FDA_Inspections

> FDA Inspection 645399 for Nassau Health Care Corporation d/b/a/ NuHealth on February 16, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 645399
- Company Name: Nassau Health Care Corporation d/b/a/ NuHealth
- Inspection Date: 2010-02-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1179788 - 2022-09-19](https://www.keypedia.com/records/fda_inspections/nassau-health-care-corporation-dba-nuhealth/3734f3f6-ddb0-48ba-bd17-721deeaff55f)
- [FDA Inspection 1179788 - 2022-09-19](https://www.keypedia.com/records/fda_inspections/nassau-health-care-corporation-dba-nuhealth/255300ee-efb0-4603-94fa-91d9b186f6e4)
- [FDA Inspection 1042421 - 2018-02-22](https://www.keypedia.com/records/fda_inspections/nassau-health-care-corporation-dba-nuhealth/94847c1f-ed55-47e8-8920-2c04a166bd6d)
- [FDA Inspection 967291 - 2016-04-08](https://www.keypedia.com/records/fda_inspections/nassau-health-care-corporation-dba-nuhealth/ae0e3580-0353-45a1-9289-06aad8f4f869)
- [FDA Inspection 856795 - 2013-11-25](https://www.keypedia.com/records/fda_inspections/nassau-health-care-corporation-dba-nuhealth/63d4dc27-8849-4b86-a8fe-4306d66173d5)

Company: https://www.keypedia.com/companies/nassau-health-care-corporation-dba-nuhealth/110a70b6-fc10-4951-a0c0-c6e9b0ab5d8d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d